# OnCo record atirmociclib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/atirmociclib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "atirmociclib" ;
  schema:name "Atirmociclib"@en ;
  schema:description "A next-generation pill that blocks only CDK4, not CDK6, to keep the benefit of today's drugs without the low blood counts."@en ;
  schema:url <https://onco.cc/drugs/atirmociclib/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06105632> ;
  onco:status "phase-3" ;
  onco:modality "Small-molecule CDK4-selective inhibitor" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/cdk46-inhibitor/> ;
  onco:targets <https://onco.cc/targets/cdk4-6/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:trials <https://onco.cc/trials/fourlight-1/>, <https://onco.cc/trials/nct04557449/>, <https://onco.cc/trials/nct04606446/>, <https://onco.cc/trials/nct06206837/>, <https://onco.cc/trials/nct07427394/>, <https://onco.cc/trials/nct05262400/>, <https://onco.cc/trials/nct06760637/> .